- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02073435
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplant
Studieoversikt
Status
Intervensjon / Behandling
Detaljert beskrivelse
This is an observational as well as a time-controlled study to be conducted at four participating A2ALL Deux Transplant Centers (TCs). The study is divided into three phases: an observational phase (Aim 1) to conduct a comprehensive and proactive patient safety risk assessment to describe preventable complications, near miss events, medical errors and hazardous conditions and in the delivery of standard of care to living donor liver transplant (LDLT) donors and recipients from the time of admission for the LDLT surgery through discharge after LDLT surgery. The in depth observational phase continues throughout the study and is scheduled to be completed by the end of the study (May 2015).
In phase 2-solution development and implementation phase (Aim 2): two high priority areas of care were identified for in depth assessment and solution development. The selection of the two high priority areas of LDLT standard of care was guided by the identification of vulnerabilities in the systems and processes of care with a high incidence and severity of related preventable complications and medical errors across the four participating A2ALL Deux TCs. To date, multiple priority areas were identified, based on the ongoing review of medical records (e.g., transition of care, glucose control, donor pain management, preoperative OR set-up). The participating A2ALL Deux TCs agreed to focus on an in depth assessment of the two areas that demonstrated high incidence and high severity of preventable complications and medical errors: 1) donor pain management and 2) preoperative OR set-up process.
Donor Pain Management:
Upon further investigation, it was identified that living liver donors experience significant amount of pain, in the early postoperative period but also especially a few days after donation. Data from the four participating A2ALL Deux TCs reveal a 20% incidence, overall, of respiratory complications (e.g. re-intubation, requirement for application of Naloxone, etc.) directly related to the opioid use in the present LDLT standard of care for donor pain management. Based on these data, clinicians at the four participating A2ALL Deux TCs, in consultation with an international pain expert with particular expertise in transplantation (Paul White, MD University of Texas Southwestern Medical Center at Dallas, Dallas, Texas), developed an evidence-based donor pain management solution with the aim of reducing preventable complications as well as improving the donor pain experience. This evidence-based donor pain management solution was developed over months through in-person and telephone meetings of transplant surgeons, hepatologists, anesthesiologists and acute pain specialists from all four participating A2ALL Deux TCs, in addition to the research teams. Consensus has been reached on the key elements of the evidence-based donor pain management solution and all four participating A2ALL Deux TCs are poised to begin implementation.
- Preoperative OR Set-up Process:
Preventable complications, near miss events, medical errors and hazardous conditions related to the preoperative OR set-up processes were identified. The four participating A2ALL Deux TCs will need to engage in additional review of the detailed assessment of the standardization and optimization of the preoperative OR set-up process and then, will collaboratively design a standardized process over a four month period (expected conclusion mid February 2014 in order to incorporate what occurs at the Collaborative at each site and overall). Solutions will be designed collaboratively to reduce the incidence and severity of related medical errors and preventable complications together with the TCs and their staff.
The measurement of solution impact to reduce preventable complications and medical errors (Aim 3) involves the implementation of the two collaboratively developed solutions: (1) Evidence-based donor pain management solution and (2) Standardization and optimization of the preoperative OR set-up process. During this phase relevant metrics pre- and post-implementation will be compared to assess the effectiveness of the implemented solutions.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
Illinois
-
Chicago, Illinois, Forente stater, 60611
- Northwestern University
-
-
Massachusetts
-
Burlington, Massachusetts, Forente stater, 01805
- Lahey Clinic
-
-
New York
-
New York, New York, Forente stater, 10032
- Columbia University
-
-
Virginia
-
Richmond, Virginia, Forente stater, 23298
- Virginia Commonweath University-Medical College of Virginia
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
CLINICIANS: All clinicians who are involved in the inpatient care provided to the LDLT A2ALL donors and recipients are eligible for the study. The group of clinicians eligible for the study involve all clinicians participating in the LDLT care between day of surgery through discharge: OR personnel (nurses, technicians, anesthesiologists, surgeons, research staff, cell saver staff, etc.), PACU/Intensive Care Unit personnel (nurses, anesthesiologists, surgeons, pharmacists, etc.) and floor personnel (nursing, coordinators, pharmacists, etc.).
PATIENTS: Living Donor Liver Transplant patients (donor and recipients) from 2008-2015.
Beskrivelse
Inclusion Criteria:
A. Clinicians
- Clinicians of both genders, of any race/ethnicity are included. Only clinicians who are unwilling to participate will be excluded.
- Clinicians and staff who are involved in the care of LDLT donors and recipients (e.g., nurses, surgeons, anesthesiologists, hepatologists, unit secretaries from medical and surgical units, ICU, transplant coordinators, pharmacists) at the four participating A2ALL Deux TCs.
B. Patients
- Every donor (≥ 21 years) and recipient involved in LDLT at the four participating A2ALL Deux TCs between 2004-2015, who were enrolled into the A2ALL cohort study Un and/or Deux. (However, to date medical record reviews were only performed for patients involved in LDLTs 2008 or later. Observations were initiated in December, 2011). After enrollment of patients into the A2ALL Deux cohort study ends (anticipated May 2014), all LDLT donors and recipients at the four participating A2ALL Deux TCs will be approached for enrollment into this ancillary A2ALL R01 patient safety study.
- Patients have not been and will not be excluded on the basis of race, gender, or any other related characteristics.
Exclusion Criteria:
- No participants will be under 21 years of age. Patients will not be excluded on the basis of age, race, gender or any other non-employment related characteristics
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Post-Implementation Group
Living Donor Liver Transplant patients with evidence based donor pain management solution.
|
The evidence-based donor pain management solution entails the following elements: Preoperative Assessment and Management:
At the end of the case in OR:
Postoperative Management:
Postoperative Assessment: o CO2 monitoring in PACU/ICU for early monitoring of respiratory depression |
Pre-Implementation Group
Living Donor Liver Transplant patients prior to the implementation of the evidence based donor pain management solution.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Living Donor Pain Management
Tidsramme: Daily Visual Analogue Pain Scores (0-10) At transplant (post-operative day 0) and throughout hospitalization (post-operative days 1-8)
|
Comparison of Average Pain Scores on Visual Analogue Pain Scale (0-10) measured before and after implementation of evidence-based donor pain management solution.
0 representing "No Pain", up through 10 representing "Worst possible, unbearable, excruciating pain".
|
Daily Visual Analogue Pain Scores (0-10) At transplant (post-operative day 0) and throughout hospitalization (post-operative days 1-8)
|
Complications
Tidsramme: Perioperatively
|
Cardiopulmonary complications
|
Perioperatively
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Daniela Ladner, MD MPH, Northwestern Univesity
- Hovedetterforsker: Donna Woods, PhD, Northwestern University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Sykdommer i fordøyelsessystemet
- Leversvikt
- Leverinsuffisiens
- Patologiske prosesser
- Neoplasmer etter histologisk type
- Neoplasmer
- Neoplasmer etter nettsted
- Adenokarsinom
- Karsinom
- Neoplasmer, kjertel og epitel
- Neoplasmer i fordøyelsessystemet
- Fibrose
- Leversykdommer
- Sluttstadium leversykdom
- Karsinom, hepatocellulært
- Levercirrhose
- Neoplasmer i leveren
Andre studie-ID-numre
- A2ALL Safety Study
- R01DK090129 (U.S. NIH-stipend/kontrakt)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Leversykdommer
-
Sisli Hamidiye Etfal Training and Research HospitalHar ikke rekruttert ennåErfaring, livTyrkia
-
Bournemouth UniversityDorset County Hospital NHS Foundation TrustFullførtErfaring, livStorbritannia
-
Universidad Complutense de MadridRekruttering
-
Swiss Federal Institute of TechnologyFullførtEldret | Uavhengig livSveits
-
Atılım UniversityHar ikke rekruttert ennåDOBBEL OPPGAVE | DEGLUTİTİON | KOGNITIV FUNKSJON | AKTIVITETER I DAGLIG LIV
-
Centre Hospitalier Universitaire DijonFullført
-
University of California, Los AngelesVA Greater Los Angeles Healthcare SystemTilbaketrukketVeteranfamilier | Familiekommunikasjon | Reintegrering av sivilt livForente stater
-
University of Erlangen-Nürnberg Medical SchoolGerman Federal Ministry of Education and Research; University of Erlangen-NürnbergFullførtUavhengig liv | Gamle og veldig gamle mennesker | FungererTyskland
-
University of ÉvoraUkjent
-
Dilek Yigit VuralFullførtSmerte | Fødsel, først | Erfaring, livTyrkia
Kliniske studier på Donor pain management
-
University of FloridaFullførtSmerte | Postoperativ smerte | Kirurgisk smerte | Nevrokirurgisk smerteForente stater
-
University of AarhusTRYG Foundation; Danish Committee for Health EducationFullførtKronisk smerteDanmark
-
Shirley Ryan AbilityLabCoapt, LLCRekrutteringAmputasjon av underekstremitet under kneet (skade) | Amputasjon av underekstremitet over kneet (skade) | Amputasjon | Fantomsmerter i lemmer | Fantomsmerte | Fantom sensasjon | Amputasjon av underekstremitet kne | Amputasjon av underekstremitet ved ankel (skade) | Amputasjon av øvre lemmer ved hånden | Amputasjon... og andre forholdForente stater
-
Université de SherbrookeQuebec Pain Research NetworkFullførtMekanisk korsryggsmerterCanada
-
University of FloridaRekrutteringKorsryggsmerter, mekanisk | Akutt smerteForente stater
-
University of WashingtonNational Center for Complementary and Integrative Health (NCCIH)Aktiv, ikke rekrutterende
-
Rigshospitalet, DenmarkThe Novo Nordic FoundationHar ikke rekruttert ennåKronisk ikke-kreft smerte
-
Dan RhonNational Center for Complementary and Integrative Health (NCCIH); 59th... og andre samarbeidspartnereRekrutteringSmerte i korsryggen | Kronisk smerte | Kirurgi | Ryggsmerter Nedre rygg Kronisk | Ryggsmerter, lavForente stater
-
University of California, Los AngelesRally Foundation for Childhood Cancer Research; Bear Necessities Pediatric...Fullført
-
The Hospital for Sick ChildrenRekrutteringTerapi-assosiert kreftCanada